Passive Immunotherapyfor viral infections withimmune humanimmunoglobulin has been usedfor many yearsinthe pro-phylaxis andtreatment of infectious disease such as RSV,CMV,rabies,hepatitis Aand B and others.Recently,ad-vances in antibody engineering have allowedthe rapid isolation and pre-clinical development of human monoclonal anti-bodies(Mab)for the treatment of humaninfectious diseases and other conditions.We have explored the use of humanmonoclonal antibodies against the newly emerged S…